| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 02/02/2005 | CN1187349C 3-(4, 5-dihydroisoxazole-5-yl)-benzoylpyrazole |
| 02/02/2005 | CN1187342C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 02/02/2005 | CN1187336C New imidazole derivatives |
| 02/02/2005 | CN1187333C Certain substituted caprolactams, pharmaceutical compositions containing them and their use in treating tumors |
| 02/02/2005 | CN1187325C Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof |
| 02/01/2005 | US6849744 3-(substituted phenyl),4-substituted-5H-1,2-oxathiole 2-oxide or 2,2-dioxide compounds useful as agricultural fungicides, insecticides, herbicides |
| 02/01/2005 | US6849739 N-heterocyclic derivatives as NOS inhibitors |
| 02/01/2005 | US6849733 Compounds containing amidated guanidine derivative type functional group of structure N-C(=N)-N-CO-N-C=N or N-C(=N)-N-CO-N |
| 02/01/2005 | US6849713 Topisomerase inhibitor |
| 02/01/2005 | US6849660 Antimicrobial biaryl compounds |
| 02/01/2005 | US6849658 Biaromatic compounds and pharmaceutical and cosmetic compositions comprising them |
| 02/01/2005 | US6849643 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 02/01/2005 | US6849639 Anticancer agents, antiinflamatory agents, osteoporosis, atherosclerosis |
| 02/01/2005 | US6849636 Useful for treatment of noninsulin-dependent diabetes, hyperglycemia, obesity, insulin resistance, dyslipidemia, hyperlipidemia, hypertension, Metabolic Syndrome |
| 02/01/2005 | US6849635 Sulfonamides |
| 02/01/2005 | US6849634 Potassium channel inhibitors |
| 02/01/2005 | US6849629 Heteroaromatic substituted sulfonyl or sulfoxide or thio-pyridazinone derivatives, useful for treating diabetic complications and cardiovascular disorders |
| 02/01/2005 | US6849622 May be useful for the prophylaxis and treatment of diabetes, particularly type 2 diabetes, and for prophylaxis and treatment of other diseases induced or exacerbated by impaired glucose tolerance |
| 02/01/2005 | US6849621 Treating: allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep |
| 01/27/2005 | WO2005007647A1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 01/27/2005 | WO2005007635A2 Combretastatin derivatives with cytotoxic action |
| 01/27/2005 | WO2005007628A1 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 01/27/2005 | WO2005007157A1 Pyrazolines as par-1 antagonists for treatment of cardiovascular diseases |
| 01/27/2005 | WO2005007111A2 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 01/27/2005 | WO2004087647A3 4-substituted quinolein derivatives with antimicrobial activity |
| 01/27/2005 | US20050020659 Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists |
| 01/27/2005 | US20050020639 Novel compounds |
| 01/27/2005 | US20050020635 C7 carbamoyloxy substituted taxane compositions |
| 01/27/2005 | US20050020630 Antiinflammatory agents; cardiovascular disorders; anticancer agents; antiarthritic agents; skin disorders; autoimmune disease; cardiovascular disorders |
| 01/27/2005 | US20050020629 Pain management |
| 01/27/2005 | US20050020624 Dihydroindole and tetrahydroquinoline derivatives |
| 01/27/2005 | US20050020618 Antidiabetic agents; obesity |
| 01/27/2005 | US20050020611 Phosphodiesterase inhibitor; antihistamines; antiallergens |
| 01/27/2005 | US20050020605 Quinolyl amide derivatives as CCR-5 antagonists |
| 01/27/2005 | US20050020604 5-HT receptor ligands and uses thereof |
| 01/27/2005 | US20050020597 Attention deficit disorders; hyperactivity; post-trauma stress disorders; anxiolytic agents; obsessive compulsive disorders; analgesics; Parkinson's disease |
| 01/27/2005 | US20050020588 Cysteine protease inhibitors |
| 01/27/2005 | US20050020583 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 01/27/2005 | US20050020578 Oxidoreductase enzyme inhibitors such as (R)-1-[4-(2-methyl-4-phenyl-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl)-pyrimidin-2-yl-ethanol, used as antidiabetic agents |
| 01/27/2005 | US20050020575 Sulfonyldihydrobenzimidazolone compounds as 5-hydroxytryptamine-6 ligands |
| 01/27/2005 | US20050020573 5HT2c receptor modulators |
| 01/27/2005 | US20050020540 Biphenylcarboxylic amide derivatives as p38-kinase inhibitors |
| 01/27/2005 | CA2532316A1 Pyrazolines as par-1 antagonists for treatment of cardiovascular diseases |
| 01/27/2005 | CA2532152A1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 01/27/2005 | CA2531389A1 Combretastatin derivatives with cytotoxic action |
| 01/27/2005 | CA2529790A1 Heteroaryloxy nitrogenous saturated heterocyclic derivative |
| 01/26/2005 | EP1500657A1 Substituted pyrazoles as P38 kinase inhibitors |
| 01/26/2005 | EP1500653A1 Substituted arylpyrazines |
| 01/26/2005 | EP1500652A1 Quinazoline derivative and medicine |
| 01/26/2005 | EP1499898A2 Regulation of tnf-alpha |
| 01/26/2005 | EP1499612A1 Piperidine ouracil used as a medicament for treating bacterial infections |
| 01/26/2005 | EP1499609A2 Pesticidal heterocycles |
| 01/26/2005 | EP1499598A1 Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions |
| 01/26/2005 | EP1499597A2 Compounds and methods for inducing apoptosis in proliferating cells |
| 01/26/2005 | EP1499594A1 Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles |
| 01/26/2005 | EP1499593A1 Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same |
| 01/26/2005 | EP1499591A1 Carboxylic acid amides |
| 01/26/2005 | EP1499577A1 2-(2,6-dichlorophenyl)-diarylimidazoles |
| 01/26/2005 | EP1499316A1 (1-4-piperidinyl)benzimidazole derivatives useful as histamine h3 antagonists |
| 01/26/2005 | EP1499314A1 N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders |
| 01/26/2005 | EP1499311A1 Substituted benzazoles and use thereof as raf kinase inhibitors |
| 01/26/2005 | EP1499308A2 Tri-substituted heteroaryls and methods of making and using the same |
| 01/26/2005 | EP1243579B1 Process for the production of pyridine derivatives |
| 01/26/2005 | EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 01/26/2005 | EP0844877B1 Use of oxido-squalene cyclase inhibitors to lower blood cholesterol |
| 01/26/2005 | CN1571786A Alkyl ether derivatives or salts thereof |
| 01/26/2005 | CN1571781A 4-imidazolin-2-one compounds |
| 01/26/2005 | CN1571667A Inhibitors of dipeptidyl peptidase ó¶ |
| 01/26/2005 | CN1186341C Diaryl perfluoro cyclopentene photochromic compounds and its preparing method and use |
| 01/26/2005 | CN1186340C C10 carbonate substituted taxanes as antitumor agents |
| 01/26/2005 | CN1186328C Substd. 5-benzyl-2, 4-diaminopyrimidines |
| 01/25/2005 | US6846954 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 01/25/2005 | US6846919 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof |
| 01/25/2005 | US6846839 Identifying indolinone compounds that inhibit growth factor stimulated cell proliferation by contacting cells with compounds and with selected growth factors and monitoring inhibitory effect |
| 01/25/2005 | US6846829 N-heterocyclic derivatives as NOS inhibitors |
| 01/25/2005 | US6846828 Aminopyrimidine and aminopyridine anti-inflammation agents |
| 01/25/2005 | US6846821 Tetrahydrothiopy ranphthalazinone derivatives as PDE4 inhibitors |
| 01/25/2005 | US6846819 Bactericides compound containing acrylamide group |
| 01/25/2005 | US6846817 Nicotine receptor ligands |
| 01/25/2005 | CA2309352C Heterocyclic-substituted tricyclics as thrombin receptor antagonists |
| 01/25/2005 | CA2103383C Quinazoline derivatives |
| 01/20/2005 | WO2005005419A1 Mch antagonists for the treatment of obesity |
| 01/20/2005 | WO2005005415A1 Indoles useful in the treatment of inflammation |
| 01/20/2005 | WO2005005411A1 Substituted indole ligands for the orl-1 receptor |
| 01/20/2005 | WO2005005393A2 Cck-1 receptor modulators |
| 01/20/2005 | WO2005005392A1 Azacyclic compounds as inhibitors of sensory neurone specific channels |
| 01/20/2005 | WO2005005374A1 Aspartyl protease inhibitors |
| 01/20/2005 | WO2005004606A2 Pyridinylanilides |
| 01/20/2005 | WO2004096129A3 Inhibitors of akt activity |
| 01/20/2005 | WO2004074218A3 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 01/20/2005 | WO2004069793A3 Novel 2-substituted cyclic amines as calcium sensing receptor modulators |
| 01/20/2005 | WO2004069792A3 Quinoline-derived amide modulators of vanilloid vr1 receptor |
| 01/20/2005 | US20050014942 Transforming growth factor inhibitor; controllign cell differentiation, cell proliferation |
| 01/20/2005 | US20050014939 E.g., N-[4-(2-Pyrrolidinylethoxy)phenyl]-4-oxo-4,5,6,7-tetrahydro-1H-indole-3-carboxamide; treating diseases associated with pathogenic agonism, inverse agonism or antagonism of the GABAA receptor such as anxiety, depression, a sleep disorder, or cognitive impairment |
| 01/20/2005 | US20050014840 Thiol sulfonamide metalloprotease inhibitors |
| 01/20/2005 | US20050014817 Fluorothiophene derivatives, process for preparing them and pharmaceutical compositions containing them |
| 01/20/2005 | US20050014816 Thiophene amino acid derivatives, process for preparing them and pharmaceutical compositions containing them |
| 01/20/2005 | US20050014815 Substituted 2-pyrrolidine-2-yl-1H-indole compounds |
| 01/20/2005 | US20050014811 Such as 4-cyclopentylamino-benzenesulfonic acid 2-(3,4-dimethoxy-phenylamino)-1H-benzoimidazol-5-yl ester; cyclin-dependent kinase inhibitors that are aimed to be more active than flavopiridol |
| 01/20/2005 | US20050014809 Substituted thien-3-yl-sulphonylamino(thio)carbonyl-triazolin(thi)ones |